chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thirst
Clinical narrative: She had an injury; full body aches; muscle pain/tension/tightness; muscle pain/tension/tightness; weakness; tiredness; extremely thirsty even though I did drink extra water; neck pain; metallic taste in mouth not long after receiving the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 28Aug2021 15:00 (Lot number: FF2588) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing); "covid-19" (unspecified if ongoing), notes: Prior to vaccination, the patient was diagnosed with COVID-19. There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "full body aches"; MYALGIA (non-serious), MUSCLE TIGHTNESS (non-serious) all with onset 29Aug2021, outcome "not recovered" and all described as "muscle pain/tension/tightness"; ASTHENIA (non-serious) with onset 29Aug2021, outcome "not recovered", described as "weakness"; FATIGUE (non-serious) with onset 29Aug2021, outcome "not recovered", described as "tiredness"; THIRST (non-serious) with onset 29Aug2021, outcome "not recovered", described as "extremely thirsty even though I did drink extra water"; NECK PAIN (non-serious) with onset 29Aug2021, outcome "not recovered", described as "neck pain"; DYSGEUSIA (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "metallic taste in mouth not long after receiving the vaccine"; INJURY (non-serious), outcome "unknown", described as "She had an injury". The events "full body aches", "muscle pain/tension/tightness", "muscle pain/tension/tightness", "weakness", "tiredness", "extremely thirsty even though i did drink extra water", "neck pain" and "metallic taste in mouth not long after receiving the vaccine" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pain, myalgia, muscle tightness, asthenia, fatigue, thirst, neck pain, dysgeusia, injury.  Additional information: Serious: NO. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Other medications the patient received within 2 weeks of vaccination: No. Prior to vaccination, the patient diagnosed with COVID-19: Yes. Since the vaccination, the patient been tested for COVID-19: No. Patient had the normal side effects which started night of vaccine. Body aches subsided the neck pain remained. She suffered a covid vaccine injury and getting treatment. Investigation Assessment: Not Provided.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dislocation of vertebra, Dizziness, Nausea, Neck pain
Clinical narrative: She had an injury; full body aches; muscle pain/tension/tightness; muscle pain/tension/tightness; weakness; tiredness; extremely thirsty even though I did drink extra water; neck pain; metallic taste in mouth not long after receiving the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 28Aug2021 15:00 (Lot number: FF2588) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing); "covid-19" (unspecified if ongoing), notes: Prior to vaccination, the patient was diagnosed with COVID-19. There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "full body aches"; MYALGIA (non-serious), MUSCLE TIGHTNESS (non-serious) all with onset 29Aug2021, outcome "not recovered" and all described as "muscle pain/tension/tightness"; ASTHENIA (non-serious) with onset 29Aug2021, outcome "not recovered", described as "weakness"; FATIGUE (non-serious) with onset 29Aug2021, outcome "not recovered", described as "tiredness"; THIRST (non-serious) with onset 29Aug2021, outcome "not recovered", described as "extremely thirsty even though I did drink extra water"; NECK PAIN (non-serious) with onset 29Aug2021, outcome "not recovered", described as "neck pain"; DYSGEUSIA (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "metallic taste in mouth not long after receiving the vaccine"; INJURY (non-serious), outcome "unknown", described as "She had an injury". The events "full body aches", "muscle pain/tension/tightness", "muscle pain/tension/tightness", "weakness", "tiredness", "extremely thirsty even though i did drink extra water", "neck pain" and "metallic taste in mouth not long after receiving the vaccine" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pain, myalgia, muscle tightness, asthenia, fatigue, thirst, neck pain, dysgeusia, injury.  Additional information: Serious: NO. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Other medications the patient received within 2 weeks of vaccination: No. Prior to vaccination, the patient diagnosed with COVID-19: Yes. Since the vaccination, the patient been tested for COVID-19: No. Patient had the normal side effects which started night of vaccine. Body aches subsided the neck pain remained. She suffered a covid vaccine injury and getting treatment. Investigation Assessment: Not Provided.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Dysgeusia, Fatigue, Injury, Muscle tightness
Clinical narrative: She had an injury; full body aches; muscle pain/tension/tightness; muscle pain/tension/tightness; weakness; tiredness; extremely thirsty even though I did drink extra water; neck pain; metallic taste in mouth not long after receiving the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 28Aug2021 15:00 (Lot number: FF2588) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing); "covid-19" (unspecified if ongoing), notes: Prior to vaccination, the patient was diagnosed with COVID-19. There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "full body aches"; MYALGIA (non-serious), MUSCLE TIGHTNESS (non-serious) all with onset 29Aug2021, outcome "not recovered" and all described as "muscle pain/tension/tightness"; ASTHENIA (non-serious) with onset 29Aug2021, outcome "not recovered", described as "weakness"; FATIGUE (non-serious) with onset 29Aug2021, outcome "not recovered", described as "tiredness"; THIRST (non-serious) with onset 29Aug2021, outcome "not recovered", described as "extremely thirsty even though I did drink extra water"; NECK PAIN (non-serious) with onset 29Aug2021, outcome "not recovered", described as "neck pain"; DYSGEUSIA (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "metallic taste in mouth not long after receiving the vaccine"; INJURY (non-serious), outcome "unknown", described as "She had an injury". The events "full body aches", "muscle pain/tension/tightness", "muscle pain/tension/tightness", "weakness", "tiredness", "extremely thirsty even though i did drink extra water", "neck pain" and "metallic taste in mouth not long after receiving the vaccine" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pain, myalgia, muscle tightness, asthenia, fatigue, thirst, neck pain, dysgeusia, injury.  Additional information: Serious: NO. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Other medications the patient received within 2 weeks of vaccination: No. Prior to vaccination, the patient diagnosed with COVID-19: Yes. Since the vaccination, the patient been tested for COVID-19: No. Patient had the normal side effects which started night of vaccine. Body aches subsided the neck pain remained. She suffered a covid vaccine injury and getting treatment. Investigation Assessment: Not Provided.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Neck pain, Pain, Thirst
Clinical narrative: She had an injury; full body aches; muscle pain/tension/tightness; muscle pain/tension/tightness; weakness; tiredness; extremely thirsty even though I did drink extra water; neck pain; metallic taste in mouth not long after receiving the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 28Aug2021 15:00 (Lot number: FF2588) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing); "covid-19" (unspecified if ongoing), notes: Prior to vaccination, the patient was diagnosed with COVID-19. There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "full body aches"; MYALGIA (non-serious), MUSCLE TIGHTNESS (non-serious) all with onset 29Aug2021, outcome "not recovered" and all described as "muscle pain/tension/tightness"; ASTHENIA (non-serious) with onset 29Aug2021, outcome "not recovered", described as "weakness"; FATIGUE (non-serious) with onset 29Aug2021, outcome "not recovered", described as "tiredness"; THIRST (non-serious) with onset 29Aug2021, outcome "not recovered", described as "extremely thirsty even though I did drink extra water"; NECK PAIN (non-serious) with onset 29Aug2021, outcome "not recovered", described as "neck pain"; DYSGEUSIA (non-serious) with onset 29Aug2021, outcome "recovered" (2021), described as "metallic taste in mouth not long after receiving the vaccine"; INJURY (non-serious), outcome "unknown", described as "She had an injury". The events "full body aches", "muscle pain/tension/tightness", "muscle pain/tension/tightness", "weakness", "tiredness", "extremely thirsty even though i did drink extra water", "neck pain" and "metallic taste in mouth not long after receiving the vaccine" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pain, myalgia, muscle tightness, asthenia, fatigue, thirst, neck pain, dysgeusia, injury.  Additional information: Serious: NO. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Other medications the patient received within 2 weeks of vaccination: No. Prior to vaccination, the patient diagnosed with COVID-19: Yes. Since the vaccination, the patient been tested for COVID-19: No. Patient had the normal side effects which started night of vaccine. Body aches subsided the neck pain remained. She suffered a covid vaccine injury and getting treatment. Investigation Assessment: Not Provided.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Chest pain, Cough, Dyspnoea, Electrocardiogram
Clinical narrative: signs and symptoms:  history of asthma presenting with 2 weeks of cough and shortness of breath and pleuritic chest pain. Went to an urgent care 2 weeks ago, started on steroids and antibiotics. ED visit 9/16 : cough, chest tight, SOB. Prolonged QTC. Treatment: sent home, told to quarantine, come back if hypoxic <90%.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pleuritic pain, SARS-CoV-2 test
Clinical narrative: signs and symptoms:  history of asthma presenting with 2 weeks of cough and shortness of breath and pleuritic chest pain. Went to an urgent care 2 weeks ago, started on steroids and antibiotics. ED visit 9/16 : cough, chest tight, SOB. Prolonged QTC. Treatment: sent home, told to quarantine, come back if hypoxic <90%.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Cough, Dyspnoea, Pleuritic pain
Clinical narrative: signs and symptoms:  history of asthma presenting with 2 weeks of cough and shortness of breath and pleuritic chest pain. Went to an urgent care 2 weeks ago, started on steroids and antibiotics. ED visit 9/16 : cough, chest tight, SOB. Prolonged QTC. Treatment: sent home, told to quarantine, come back if hypoxic <90%.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiotensin converting enzyme, Borrelia test, Electromyogram, Herpes virus test, Laboratory test
Clinical narrative: Muscle tightness, extreme fatigue and weakness. Loss of coordination, severely hampered ability to walk. Tingling in hands and feet along with numbness. Decreased heart rate. Hospitalization, IVIG infusions, physical and occupational therapy. Almost 4 months past injection date, still have weakness and general tiredness, hands and arms still tingle like they are asleep. Struggle with some simple tasks such as showering and getting dressed. Specifically putting on socks and pants(I must be seated to do so). Potential lifelong effects with no recourse due to EAU protections. PCP believed had I not received treatment when I did I would have ended up on a ventilator
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging spinal, Muscular weakness, Sensory disturbance
Clinical narrative: Muscle tightness, extreme fatigue and weakness. Loss of coordination, severely hampered ability to walk. Tingling in hands and feet along with numbness. Decreased heart rate. Hospitalization, IVIG infusions, physical and occupational therapy. Almost 4 months past injection date, still have weakness and general tiredness, hands and arms still tingle like they are asleep. Struggle with some simple tasks such as showering and getting dressed. Specifically putting on socks and pants(I must be seated to do so). Potential lifelong effects with no recourse due to EAU protections. PCP believed had I not received treatment when I did I would have ended up on a ventilator
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood test, Computerised tomogram, Coordination abnormal, Electromyogram
Clinical narrative: Muscle tightness, extreme fatigue and weakness. Loss of coordination, severely hampered ability to walk. Tingling in hands and feet along with numbness. Decreased heart rate. Hospitalization, IVIG infusions, physical and occupational therapy. Almost 4 months past injection date, still have weakness and general tiredness, hands and arms still tingle like they are asleep. Struggle with some simple tasks such as showering and getting dressed. Specifically putting on socks and pants(I must be seated to do so). Potential lifelong effects with no recourse due to EAU protections. PCP believed had I not received treatment when I did I would have ended up on a ventilator
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Gait disturbance, Heart rate decreased, Hypoaesthesia, Immunoglobulin therapy
Clinical narrative: Muscle tightness, extreme fatigue and weakness. Loss of coordination, severely hampered ability to walk. Tingling in hands and feet along with numbness. Decreased heart rate. Hospitalization, IVIG infusions, physical and occupational therapy. Almost 4 months past injection date, still have weakness and general tiredness, hands and arms still tingle like they are asleep. Struggle with some simple tasks such as showering and getting dressed. Specifically putting on socks and pants(I must be seated to do so). Potential lifelong effects with no recourse due to EAU protections. PCP believed had I not received treatment when I did I would have ended up on a ventilator
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Lumbar puncture, Magnetic resonance imaging, Muscle tightness, Nerve conduction studies
Clinical narrative: Muscle tightness, extreme fatigue and weakness. Loss of coordination, severely hampered ability to walk. Tingling in hands and feet along with numbness. Decreased heart rate. Hospitalization, IVIG infusions, physical and occupational therapy. Almost 4 months past injection date, still have weakness and general tiredness, hands and arms still tingle like they are asleep. Struggle with some simple tasks such as showering and getting dressed. Specifically putting on socks and pants(I must be seated to do so). Potential lifelong effects with no recourse due to EAU protections. PCP believed had I not received treatment when I did I would have ended up on a ventilator
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Muscle tightness, extreme fatigue and weakness. Loss of coordination, severely hampered ability to walk. Tingling in hands and feet along with numbness. Decreased heart rate. Hospitalization, IVIG infusions, physical and occupational therapy. Almost 4 months past injection date, still have weakness and general tiredness, hands and arms still tingle like they are asleep. Struggle with some simple tasks such as showering and getting dressed. Specifically putting on socks and pants(I must be seated to do so). Potential lifelong effects with no recourse due to EAU protections. PCP believed had I not received treatment when I did I would have ended up on a ventilator
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Pulse of 140/ Extremely High Blood Pressure Rushed to ER 10 minutes after vaccination
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ambulatory, Hypertension
Clinical narrative: Pulse of 140/ Extremely High Blood Pressure Rushed to ER 10 minutes after vaccination
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Hysteroscopy, Menstrual disorder, Surgery, Ultrasound scan
Clinical narrative: 24 hours after the first shot, I began menstruating heavily; I subsequently was intermittingly bleeding every day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Jan2021 (Lot number: EL3249) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "menstruating heavily" (unspecified if ongoing); "did not menstruate monthly because of Mirena" (unspecified if ongoing). Concomitant medication(s) included: MIRENA. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 23Jan2021, outcome "not recovered", described as "24 hours after the first shot, I began menstruating heavily"; INTERMENSTRUAL BLEEDING (non-serious) with onset 23Jan2021, outcome "not recovered", described as "I subsequently was intermittingly bleeding every day". The events "24 hours after the first shot, i began menstruating heavily" and "i subsequently was intermittingly bleeding every day" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heavy menstrual bleeding, intermenstrual bleeding.  Additional information: The patient later received second dose of BNT162B2 on 15Feb2021 (lot number: EN6201) in the left arm and 24 hours after the shot, she had very heavy bleeding and in the days after, she had intermittent bleeding that did not stop. The patient did not receive other vaccine in four weeks. The patient did not have Covid prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Uterine leiomyoma
Clinical narrative: 24 hours after the first shot, I began menstruating heavily; I subsequently was intermittingly bleeding every day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Jan2021 (Lot number: EL3249) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "menstruating heavily" (unspecified if ongoing); "did not menstruate monthly because of Mirena" (unspecified if ongoing). Concomitant medication(s) included: MIRENA. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 23Jan2021, outcome "not recovered", described as "24 hours after the first shot, I began menstruating heavily"; INTERMENSTRUAL BLEEDING (non-serious) with onset 23Jan2021, outcome "not recovered", described as "I subsequently was intermittingly bleeding every day". The events "24 hours after the first shot, i began menstruating heavily" and "i subsequently was intermittingly bleeding every day" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heavy menstrual bleeding, intermenstrual bleeding.  Additional information: The patient later received second dose of BNT162B2 on 15Feb2021 (lot number: EN6201) in the left arm and 24 hours after the shot, she had very heavy bleeding and in the days after, she had intermittent bleeding that did not stop. The patient did not receive other vaccine in four weeks. The patient did not have Covid prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Intermenstrual bleeding, SARS-CoV-2 test, Ultrasound scan
Clinical narrative: 24 hours after the first shot, I began menstruating heavily; I subsequently was intermittingly bleeding every day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Jan2021 (Lot number: EL3249) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "menstruating heavily" (unspecified if ongoing); "did not menstruate monthly because of Mirena" (unspecified if ongoing). Concomitant medication(s) included: MIRENA. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 23Jan2021, outcome "not recovered", described as "24 hours after the first shot, I began menstruating heavily"; INTERMENSTRUAL BLEEDING (non-serious) with onset 23Jan2021, outcome "not recovered", described as "I subsequently was intermittingly bleeding every day". The events "24 hours after the first shot, i began menstruating heavily" and "i subsequently was intermittingly bleeding every day" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heavy menstrual bleeding, intermenstrual bleeding.  Additional information: The patient later received second dose of BNT162B2 on 15Feb2021 (lot number: EN6201) in the left arm and 24 hours after the shot, she had very heavy bleeding and in the days after, she had intermittent bleeding that did not stop. The patient did not receive other vaccine in four weeks. The patient did not have Covid prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, Cardiac monitoring abnormal, Chest pain, Condition aggravated
Clinical narrative: CHIEF COMPLAINT:   arrives with son whom see's mother once every other week with concerns of home health safety. pt. has been declining over last month with ADL's. Covid + 2 weeks ago/quaratine over. pt. has no complaints. been falling down at home.   HISTORY OF PRESENT ILLNESS:     78 yo female with PMH of Afib with RVR, encephalopathy, blood loss anemia 2/2 likely upper GI bleed/B12/folate deficiency, alcohol abuse, electrolytes imbalance, recent COVID infection, recent hospitalization who presents to the emergency room today after her son was called by patient significant other that she was on the floor and unable to get up.  Son reports that she was on the floor for unknown amount of time however at least an hour.   Son states that first time he seen her since her discharge.  He reports that his mom is confused and not at her baseline.  He also reports that she is having a functional decline; last month she was walking without assistance and now she is unable to get out of bed, unable to get herself off the floor.  He is not sure whether patient has been falling but feels like she has she still confused.  Son reports that patient was set up with the words at home however she and her significant other declined any services and thus she never received any.  Patient did not follow-up with PCP.  Patient states that her significant other is unable to take care of her as he is diabetic and has his own medical concerns.   Patient is very and oriented x2, however she is poor historian not answering appropriately to questioning.  Patient reports no pain and no discomfort anywhere.  See note reviewed
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Hypophagia, Hypovitaminosis, Mobility decreased, Nausea
Clinical narrative: CHIEF COMPLAINT:   arrives with son whom see's mother once every other week with concerns of home health safety. pt. has been declining over last month with ADL's. Covid + 2 weeks ago/quaratine over. pt. has no complaints. been falling down at home.   HISTORY OF PRESENT ILLNESS:     78 yo female with PMH of Afib with RVR, encephalopathy, blood loss anemia 2/2 likely upper GI bleed/B12/folate deficiency, alcohol abuse, electrolytes imbalance, recent COVID infection, recent hospitalization who presents to the emergency room today after her son was called by patient significant other that she was on the floor and unable to get up.  Son reports that she was on the floor for unknown amount of time however at least an hour.   Son states that first time he seen her since her discharge.  He reports that his mom is confused and not at her baseline.  He also reports that she is having a functional decline; last month she was walking without assistance and now she is unable to get out of bed, unable to get herself off the floor.  He is not sure whether patient has been falling but feels like she has she still confused.  Son reports that patient was set up with the words at home however she and her significant other declined any services and thus she never received any.  Patient did not follow-up with PCP.  Patient states that her significant other is unable to take care of her as he is diabetic and has his own medical concerns.   Patient is very and oriented x2, however she is poor historian not answering appropriately to questioning.  Patient reports no pain and no discomfort anywhere.  See note reviewed
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oedema peripheral, SARS-CoV-2 test positive, Transfusion
Clinical narrative: CHIEF COMPLAINT:   arrives with son whom see's mother once every other week with concerns of home health safety. pt. has been declining over last month with ADL's. Covid + 2 weeks ago/quaratine over. pt. has no complaints. been falling down at home.   HISTORY OF PRESENT ILLNESS:     78 yo female with PMH of Afib with RVR, encephalopathy, blood loss anemia 2/2 likely upper GI bleed/B12/folate deficiency, alcohol abuse, electrolytes imbalance, recent COVID infection, recent hospitalization who presents to the emergency room today after her son was called by patient significant other that she was on the floor and unable to get up.  Son reports that she was on the floor for unknown amount of time however at least an hour.   Son states that first time he seen her since her discharge.  He reports that his mom is confused and not at her baseline.  He also reports that she is having a functional decline; last month she was walking without assistance and now she is unable to get out of bed, unable to get herself off the floor.  He is not sure whether patient has been falling but feels like she has she still confused.  Son reports that patient was set up with the words at home however she and her significant other declined any services and thus she never received any.  Patient did not follow-up with PCP.  Patient states that her significant other is unable to take care of her as he is diabetic and has his own medical concerns.   Patient is very and oriented x2, however she is poor historian not answering appropriately to questioning.  Patient reports no pain and no discomfort anywhere.  See note reviewed
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Confusional state, Dysstasia, Fall, General physical health deterioration
Clinical narrative: CHIEF COMPLAINT:   arrives with son whom see's mother once every other week with concerns of home health safety. pt. has been declining over last month with ADL's. Covid + 2 weeks ago/quaratine over. pt. has no complaints. been falling down at home.   HISTORY OF PRESENT ILLNESS:     78 yo female with PMH of Afib with RVR, encephalopathy, blood loss anemia 2/2 likely upper GI bleed/B12/folate deficiency, alcohol abuse, electrolytes imbalance, recent COVID infection, recent hospitalization who presents to the emergency room today after her son was called by patient significant other that she was on the floor and unable to get up.  Son reports that she was on the floor for unknown amount of time however at least an hour.   Son states that first time he seen her since her discharge.  He reports that his mom is confused and not at her baseline.  He also reports that she is having a functional decline; last month she was walking without assistance and now she is unable to get out of bed, unable to get herself off the floor.  He is not sure whether patient has been falling but feels like she has she still confused.  Son reports that patient was set up with the words at home however she and her significant other declined any services and thus she never received any.  Patient did not follow-up with PCP.  Patient states that her significant other is unable to take care of her as he is diabetic and has his own medical concerns.   Patient is very and oriented x2, however she is poor historian not answering appropriately to questioning.  Patient reports no pain and no discomfort anywhere.  See note reviewed
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Mobility decreased, SARS-CoV-2 test positive
Clinical narrative: CHIEF COMPLAINT:   arrives with son whom see's mother once every other week with concerns of home health safety. pt. has been declining over last month with ADL's. Covid + 2 weeks ago/quaratine over. pt. has no complaints. been falling down at home.   HISTORY OF PRESENT ILLNESS:     78 yo female with PMH of Afib with RVR, encephalopathy, blood loss anemia 2/2 likely upper GI bleed/B12/folate deficiency, alcohol abuse, electrolytes imbalance, recent COVID infection, recent hospitalization who presents to the emergency room today after her son was called by patient significant other that she was on the floor and unable to get up.  Son reports that she was on the floor for unknown amount of time however at least an hour.   Son states that first time he seen her since her discharge.  He reports that his mom is confused and not at her baseline.  He also reports that she is having a functional decline; last month she was walking without assistance and now she is unable to get out of bed, unable to get herself off the floor.  He is not sure whether patient has been falling but feels like she has she still confused.  Son reports that patient was set up with the words at home however she and her significant other declined any services and thus she never received any.  Patient did not follow-up with PCP.  Patient states that her significant other is unable to take care of her as he is diabetic and has his own medical concerns.   Patient is very and oriented x2, however she is poor historian not answering appropriately to questioning.  Patient reports no pain and no discomfort anywhere.  See note reviewed
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Thrombosis, Ultrasound scan abnormal
Clinical narrative: sudden severe pain, swelling, redness in left lower extremity. unable to bear weight. went to ER. ultrasound showed blood clot from groin to ankle in left leg. follow up blood tests for clotting issues were normal. swelling, pain, fatigue, skin issues still persist.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Anti factor V antibody, Antiphospholipid antibodies, Dysstasia, Erythema
Clinical narrative: sudden severe pain, swelling, redness in left lower extremity. unable to bear weight. went to ER. ultrasound showed blood clot from groin to ankle in left leg. follow up blood tests for clotting issues were normal. swelling, pain, fatigue, skin issues still persist.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, International normalised ratio, Laboratory test, Pain, Protein C
Clinical narrative: sudden severe pain, swelling, redness in left lower extremity. unable to bear weight. went to ER. ultrasound showed blood clot from groin to ankle in left leg. follow up blood tests for clotting issues were normal. swelling, pain, fatigue, skin issues still persist.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Protein S, Prothrombin time, Russell's viper venom time, Skin disorder, Swelling
Clinical narrative: sudden severe pain, swelling, redness in left lower extremity. unable to bear weight. went to ER. ultrasound showed blood clot from groin to ankle in left leg. follow up blood tests for clotting issues were normal. swelling, pain, fatigue, skin issues still persist.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis, Ultrasound scan abnormal
Clinical narrative: sudden severe pain, swelling, redness in left lower extremity. unable to bear weight. went to ER. ultrasound showed blood clot from groin to ankle in left leg. follow up blood tests for clotting issues were normal. swelling, pain, fatigue, skin issues still persist.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Cystitis interstitial, Extra dose administered, Malaise, Urinary tract infection
Clinical narrative: This spontaneous report received from a patient via a regulatory authority vaccine adverse event reporting system (ID: 1901941) concerned a 67-year-old female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: Hashimoto's, gluten allergy, sulfa allergy, and contrast dye allergy. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 1802072 expiries: UNKNOWN) dose was not reported, 1 total, administered on 11-MAR-2021 to left arm for an unknown indication. (Dose number series 1). No concomitant medications were reported. On JUL-2021, the patient experienced urinary tract infection. A few weeks later it all cleared up and the patient felt fine all summer. Laboratory data (dates unspecified) included: Laboratory test (NR: not provided) no bacteria was found. The drug start period was 106 days. (Dose number series 1) The action taken with covid-19 vaccine was not applicable. The patient recovered from urinary tract infection. This report was not serious. This case, involving the same patient is linked to 20211225969. (Dose number in series 2 case).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis, Vertigo, Vomiting
Clinical narrative: This spontaneous report received from a patient via a regulatory authority vaccine adverse event reporting system (ID: 1901941) concerned a 67-year-old female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: Hashimoto's, gluten allergy, sulfa allergy, and contrast dye allergy. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 1802072 expiries: UNKNOWN) dose was not reported, 1 total, administered on 11-MAR-2021 to left arm for an unknown indication. (Dose number series 1). No concomitant medications were reported. On JUL-2021, the patient experienced urinary tract infection. A few weeks later it all cleared up and the patient felt fine all summer. Laboratory data (dates unspecified) included: Laboratory test (NR: not provided) no bacteria was found. The drug start period was 106 days. (Dose number series 1) The action taken with covid-19 vaccine was not applicable. The patient recovered from urinary tract infection. This report was not serious. This case, involving the same patient is linked to 20211225969. (Dose number in series 2 case).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Urinary tract infection
Clinical narrative: This spontaneous report received from a patient via a regulatory authority vaccine adverse event reporting system (ID: 1901941) concerned a 67-year-old female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: Hashimoto's, gluten allergy, sulfa allergy, and contrast dye allergy. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 1802072 expiries: UNKNOWN) dose was not reported, 1 total, administered on 11-MAR-2021 to left arm for an unknown indication. (Dose number series 1). No concomitant medications were reported. On JUL-2021, the patient experienced urinary tract infection. A few weeks later it all cleared up and the patient felt fine all summer. Laboratory data (dates unspecified) included: Laboratory test (NR: not provided) no bacteria was found. The drug start period was 106 days. (Dose number series 1) The action taken with covid-19 vaccine was not applicable. The patient recovered from urinary tract infection. This report was not serious. This case, involving the same patient is linked to 20211225969. (Dose number in series 2 case).
Age: 6.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Pharyngeal swelling, Tachycardia, Throat irritation
Clinical narrative: Within five minutes of injection, an itchy welt appeared (baseball sized), with smaller hives radiating out
Age: 6.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Within five minutes of injection, an itchy welt appeared (baseball sized), with smaller hives radiating out
Age: 5.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Electrocardiogram, Syncope, Urticaria
Clinical narrative: Patient went to the emergency room twice. She had an on and off rash that was controlled with Benadryl. Doctor then prescribed hydroxyzine, since she had face swelling.
Age: 5.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Swelling face
Clinical narrative: Patient went to the emergency room twice. She had an on and off rash that was controlled with Benadryl. Doctor then prescribed hydroxyzine, since she had face swelling.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Chest X-ray, Chest pain, Chills
Clinical narrative: booster; blood clot in right lung; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 36-year-old female patient received BNT162B2, administered in arm right, administration date 30Nov2021 (Batch/Lot number: unknown) at the age of 36 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "UTI", start date: Nov2021 (unspecified if ongoing), notes: 3 weeks ago, blood work: (Nov2021) urinary tract infection; "high blood pressure" (unspecified if ongoing). The patient took concomitant medications (high blood pressure). She did not have vaccination 4 weeks prior to COVID 19 Vaccine. The following information was reported: IMMUNISATION (hospitalization, medically significant) with onset 30Nov2021, described as "booster"; PULMONARY THROMBOSIS (hospitalization, medically significant) with onset 2021, outcome "unknown", described as "blood clot in right lung". The patient took the Pfizer shot and developed blood clot in the lungs, stated that "it almost killed me." So, patient was making a complaint about this shot. She just got out of the hospital. Further stated, "almost took my life, you almost took my life.. almost died from this shot." She come from being healthy to now, got to take the blood thinner (treatment) for 6 months because she took this shot. She got admitted in hospital; she developed blood clot and stayed in hospital and got medicine every time. She was on everything, on blood thinner. Now, almost 2 months for the blood clots to leave.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Coagulation test, Differential white blood cell count, Dyspnoea, Echocardiogram, Electrocardiogram
Clinical narrative: booster; blood clot in right lung; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 36-year-old female patient received BNT162B2, administered in arm right, administration date 30Nov2021 (Batch/Lot number: unknown) at the age of 36 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "UTI", start date: Nov2021 (unspecified if ongoing), notes: 3 weeks ago, blood work: (Nov2021) urinary tract infection; "high blood pressure" (unspecified if ongoing). The patient took concomitant medications (high blood pressure). She did not have vaccination 4 weeks prior to COVID 19 Vaccine. The following information was reported: IMMUNISATION (hospitalization, medically significant) with onset 30Nov2021, described as "booster"; PULMONARY THROMBOSIS (hospitalization, medically significant) with onset 2021, outcome "unknown", described as "blood clot in right lung". The patient took the Pfizer shot and developed blood clot in the lungs, stated that "it almost killed me." So, patient was making a complaint about this shot. She just got out of the hospital. Further stated, "almost took my life, you almost took my life.. almost died from this shot." She come from being healthy to now, got to take the blood thinner (treatment) for 6 months because she took this shot. She got admitted in hospital; she developed blood clot and stayed in hospital and got medicine every time. She was on everything, on blood thinner. Now, almost 2 months for the blood clots to leave.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Full blood count, Laboratory test, Malaise, Muscle spasms
Clinical narrative: booster; blood clot in right lung; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 36-year-old female patient received BNT162B2, administered in arm right, administration date 30Nov2021 (Batch/Lot number: unknown) at the age of 36 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "UTI", start date: Nov2021 (unspecified if ongoing), notes: 3 weeks ago, blood work: (Nov2021) urinary tract infection; "high blood pressure" (unspecified if ongoing). The patient took concomitant medications (high blood pressure). She did not have vaccination 4 weeks prior to COVID 19 Vaccine. The following information was reported: IMMUNISATION (hospitalization, medically significant) with onset 30Nov2021, described as "booster"; PULMONARY THROMBOSIS (hospitalization, medically significant) with onset 2021, outcome "unknown", described as "blood clot in right lung". The patient took the Pfizer shot and developed blood clot in the lungs, stated that "it almost killed me." So, patient was making a complaint about this shot. She just got out of the hospital. Further stated, "almost took my life, you almost took my life.. almost died from this shot." She come from being healthy to now, got to take the blood thinner (treatment) for 6 months because she took this shot. She got admitted in hospital; she developed blood clot and stayed in hospital and got medicine every time. She was on everything, on blood thinner. Now, almost 2 months for the blood clots to leave.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pregnancy test, Pulmonary embolism, Pulmonary endarterectomy, SARS-CoV-2 test
Clinical narrative: booster; blood clot in right lung; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 36-year-old female patient received BNT162B2, administered in arm right, administration date 30Nov2021 (Batch/Lot number: unknown) at the age of 36 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "UTI", start date: Nov2021 (unspecified if ongoing), notes: 3 weeks ago, blood work: (Nov2021) urinary tract infection; "high blood pressure" (unspecified if ongoing). The patient took concomitant medications (high blood pressure). She did not have vaccination 4 weeks prior to COVID 19 Vaccine. The following information was reported: IMMUNISATION (hospitalization, medically significant) with onset 30Nov2021, described as "booster"; PULMONARY THROMBOSIS (hospitalization, medically significant) with onset 2021, outcome "unknown", described as "blood clot in right lung". The patient took the Pfizer shot and developed blood clot in the lungs, stated that "it almost killed me." So, patient was making a complaint about this shot. She just got out of the hospital. Further stated, "almost took my life, you almost took my life.. almost died from this shot." She come from being healthy to now, got to take the blood thinner (treatment) for 6 months because she took this shot. She got admitted in hospital; she developed blood clot and stayed in hospital and got medicine every time. She was on everything, on blood thinner. Now, almost 2 months for the blood clots to leave.  The lot number for bnt162b2 was not provided and will be requested during follow up.